Aziyo Biologics Retained Earnings 2011-2026 | AZYO

Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.

Possible uses include

reinvestment in development (R&D, equipment, marketing)
debt repayment
acquisition of other companies
creation of reserves for the future

A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.

The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.

Annual Retained Earnings Aziyo Biologics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-176 M	-138 M	-105 M	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-105 M	-176 M	-140 M

Quarterly Retained Earnings Aziyo Biologics

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-247 M	-243 M	-234 M	-221 M	-222 M	-194 M	-166 M	-157 M	-146 M	-138 M	-133 M	-123 M	-113 M	-105 M	-96 M	-87.7 M	-85.3 M	-80.3 M	-80.3 M	-80.3 M	-80.3 M	-56.9 M	-56.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
-56.9 M	-247 M	-137 M

Retained Earnings of other stocks in the Medical devices industry

Issuer	Retained Earnings	Price	% 24h	Market Cap	Country
Delcath Systems DCTH	-529 M	$ 9.11	-10.77 %	$ 260 M	USA
Acutus Medical AFIB	-600 M	-	-26.83 %	$ 2.62 M	USA
Allied Healthcare Products AHPI	-15.7 M	-	3.58 %	$ 2.21 M	USA
GenMark Diagnostics, Inc. GNMK	-533 M	-	-	$ 1.77 B	USA
Apollo Endosurgery APEN	-337 M	-	-	$ 475 M	USA
Alphatec Holdings ATEC	-1.42 B	$ 13.94	-0.71 %	$ 2.09 B	USA
Obalon Therapeutics, Inc. OBLN	-185 M	-	-5.86 %	$ 30.6 M	USA
Cognyte Software Ltd. CGNT	-157 M	$ 7.0	5.74 %	$ 503 M	Israel
EDAP TMS S.A. EDAP	-82.6 M	$ 4.38	-4.58 %	$ 163 M	France
Axonics Modulation Technologies AXNX	-374 M	-	-	$ 3.31 B	USA
Avinger AVGR	-421 M	-	-20.74 %	$ 369 K	USA
Apyx Medical Corporation APYX	-54.4 M	$ 3.49	2.05 %	$ 121 M	USA
AxoGen AXGN	-307 M	$ 31.87	2.07 %	$ 1.47 B	USA
Bio-Rad Laboratories BIO	7.42 B	$ 275.33	2.19 %	$ 7.77 B	USA
BIOLASE BIOL	-317 M	-	-13.19 %	$ 166 K	USA
Bruker Corporation BRKR	2.41 B	$ 40.88	2.48 %	$ 6.09 K	USA
BioSig Technologies BSGM	-255 M	-	37.08 %	$ 85.7 M	USA
Boston Scientific Corporation BSX	5.57 B	$ 75.65	2.97 %	$ 112 B	USA
InMode Ltd. INMD	969 M	$ 14.0	0.29 %	$ 905 M	Israel
CryoLife, Inc. CRY	20 M	-	-4.14 %	$ 702 M	USA
Conformis CFMS	-581 M	-	-	$ 16.4 M	USA
ClearPoint Neuro CLPT	-191 M	$ 14.09	-7.06 %	$ 381 M	USA
CONMED Corporation CNMD	589 M	$ 45.89	-0.18 %	$ 1.42 B	USA
Soliton, Inc. SOLY	-70.6 M	-	-1.42 %	$ 435 M	USA
Hancock Jaffe Laboratories, Inc. HJLI	-56.2 M	-	-1.98 %	$ 98.3 M	USA
Itamar Medical Ltd. ITMR	-119 M	-	0.03 %	$ 1.58 B	Israel
Misonix, Inc. MSON	-39.3 M	-	-	$ 462 M	USA
Neovasc NVCN	-395 M	-	-	$ 111 M	Canada
Cardiovascular Systems CSII	-424 M	-	0.15 %	$ 844 M	USA
Cutera CUTR	-303 M	-	-10.19 %	$ 1.99 M	USA
Nano-X Imaging Ltd. NNOX	-374 M	$ 2.48	1.02 %	$ 146 M	Israel
Intersect ENT, Inc. XENT	-303 M	-	-	$ 955 M	USA
Dynatronics Corporation DYNT	-40.5 M	-	14.99 %	$ 929 K	USA
Eargo EAR	-514 M	-	-	$ 10.2 M	USA
Electromed ELMD	21.2 M	$ 24.18	1.09 %	$ 204 M	USA
Establishment Labs Holdings ESTA	-445 M	$ 77.41	-1.12 %	$ 2.18 B	Costa-rica
Second Sight Medical Products EYES	-122 M	-	-0.97 %	$ 54.4 M	USA
FONAR Corporation FONR	-33.6 M	$ 18.53	-0.3 %	$ 121 M	USA
GBS GBS	-62.5 M	-	-0.57 %	$ 7.12 M	USA
Globus Medical GMED	1.39 B	$ 96.27	0.06 %	$ 13 B	USA
Tandem Diabetes Care TNDM	-1.25 B	$ 26.14	0.5 %	$ 1.78 B	USA
Helius Medical Technologies HSDT	-160 M	$ 2.11	-2.76 %	$ 1.28 M	USA
Integra LifeSciences Holdings Corporation IART	940 M	$ 11.13	-4.01 %	$ 857 M	USA
Cytosorbents Corporation CTSO	-304 M	$ 0.73	2.57 %	$ 39.7 M	USA
Inogen INGN	-153 M	$ 6.4	6.53 %	$ 151 M	USA
IRIDEX Corporation IRIX	-79 M	$ 1.47	-2.0 %	$ 23.7 M	USA
IRadimed Corporation IRMD	56.8 M	$ 102.4	1.89 %	$ 1.3 B	USA